Inspire Medical Systems, Inc. INSP
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 314.00K | -11.29M | 136.09M | 9.93M | -3.59M |
| Total Depreciation and Amortization | 4.60M | 5.11M | 3.82M | 3.68M | 3.41M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 41.15M | 32.14M | -60.59M | 29.48M | 45.42M |
| Change in Net Operating Assets | -22.83M | -13.11M | -26.85M | 25.44M | -42.56M |
| Cash from Operations | 23.23M | 12.85M | 52.47M | 68.53M | 2.68M |
| Capital Expenditure | -9.16M | -9.73M | -10.66M | -10.44M | -9.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 12.71M | -1.52M | -1.26M | -1.21M | 55.56M |
| Cash from Investing | 3.55M | -11.25M | -11.92M | -11.65M | 46.56M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.60M | 109.00K | 2.40M | 347.00K | 5.43M |
| Repurchase of Common Stock | -685.00K | -7.59M | -50.71M | -51.43M | -1.73M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.91M | -7.48M | -48.31M | -51.08M | 3.70M |
| Foreign Exchange rate Adjustments | 142.00K | 1.00K | -275.00K | 115.00K | 102.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28.83M | -5.88M | -8.03M | 5.92M | 53.05M |